Sponsor or institution
Clinical trials and research at Beijing Continent Pharmaceutical Co, Ltd.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Beijing Continent Pharmaceutical Co, Ltd. that are recruiting, in China. By phase: Phase 3 (2), Phase 1 (2), Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pirfenidone for radiation-related and immune-related lung injury | Phase 2/3 | Hefei, Anhui and 35 other locations | Recruiting | Feb 5, 2026 |
| Single-dose hydroxynidone for people with reduced kidney function | Phase 1 | Hubei, Wuhan | Recruiting | Dec 3, 2025 |
| First human dosing of F230 tablets | Phase 1 | Hubei, Wuhan | Recruiting | Mar 28, 2025 |
| Long-term treatment with hydronidone capsules for liver fibrosis in hepatitis B patients | Phase 3 | Beijing, Beijing Municipality and 22 other locations | Recruiting | Jun 15, 2023 |
| F573 injection for treating liver injury and failure | Phase 2 | Beijing, Beijing Municipality and 9 other locations | Recruiting | Jan 19, 2023 |
| Pirfenidone capsules to treat pneumoconiosis. | Phase 3 | Beijing | Recruiting | Mar 21, 2022 |
All recruiting trials (6)
-
Pirfenidone for radiation-related and immune-related lung injury
This trial will try pirfenidone capsules to treat adults who develop radiation-induced lung injury or immune checkpoint inhibitor–related pneumonitis.
-
Single-dose hydroxynidone for people with reduced kidney function
This trial will test a single dose of hydroxynidone to see how the drug is processed and tolerated in people with renal insufficiency compared with healthy volunteers.
-
First human dosing of F230 tablets
This study will test whether single and multiple doses of F230 tablets are safe and how the body processes them in healthy adult volunteers.
-
Long-term treatment with hydronidone capsules for liver fibrosis in hepatitis B patients
This study is testing if taking hydronidone capsules for a longer time can help people with liver fibrosis caused by hepatitis B feel better and improve their liver health.
-
F573 injection for treating liver injury and failure
This study is testing if an injection called F573 can help people with liver injury or chronic hepatitis B feel better and recover.
-
Pirfenidone capsules to treat pneumoconiosis.
This 52-week test will see if pirfenidone capsules help adults aged 18–70 with pneumoconiosis compared with placebo.
Quick answers
How many clinical trials run by Beijing Continent Pharmaceutical Co, Ltd. are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.